(Editor's note: John Burke is president of National Association of Drug Diversion Investigators and Pharmaceutical Diversion Education Inc., which provide educational and consulting services on…
The CEO of a company that recently introduced a new and more potent opioid painkiller is blaming “false and misleading statements” – including allegations by…
Zohydro has some competition. Just days after drug maker Zogenix Inc. (NASDAQ: ZGNX) began sales of the first pure hydrocodone painkiller in the United States,…
Drug maker Zogenix Inc. (NASDAQ: ZGNX) says its controversial new opioid painkiller Zohydro is now available in “select” pharmacies in the United States, a drug…
A coalition of addiction treatment experts, healthcare agencies and consumer groups is calling on the Food and Drug Administration to revoke its approval of Zohydro,…
Oxycodone and hydrocodone are the “drugs of choice” for abusers of opioid pain medication, according to a new survey of thousands of opioid addicts entering…